BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30900017)

  • 1. miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway.
    Lou Z; Peng Z; Wang B; Li X; Li X; Zhang X
    J Bone Miner Metab; 2019 Sep; 37(5):815-824. PubMed ID: 30900017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
    Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
    RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioacetamide promotes osteoclast transformation of bone marrow macrophages by influencing PI3K/AKT pathways.
    Jin X; Li Y; Yang Y; Shen H; Chen J; Xu B; Xu J
    J Orthop Surg Res; 2022 Jan; 17(1):53. PubMed ID: 35093114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis.
    Wang CG; Wang L; Yang T; Su SL; Hu YH; Zhong D
    Cytotherapy; 2020 Aug; 22(8):412-423. PubMed ID: 32561161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-138-5p promotes TNF-α-induced apoptosis in human intervertebral disc degeneration by targeting SIRT1 through PTEN/PI3K/Akt signaling.
    Wang B; Wang D; Yan T; Yuan H
    Exp Cell Res; 2016 Jul; 345(2):199-205. PubMed ID: 27207584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting PTEN.
    Wang M; Zhao M; Guo Q; Lou J; Wang L
    Exp Cell Res; 2021 Nov; 408(1):112834. PubMed ID: 34537206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
    Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑21 promotes osteoclastogenesis through activation of PI3K/Akt signaling by targeting Pten in RAW264.7 cells.
    Wang S; Liu Z; Wang J; Ji X; Yao Z; Wang X
    Mol Med Rep; 2020 Mar; 21(3):1125-1132. PubMed ID: 32016444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B.
    Sun L; Lian JX; Meng S
    Cell Mol Biol Lett; 2019; 24():23. PubMed ID: 30976285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p.
    Zhang L; Lv Y; Xian G; Lin Y
    Biochem Biophys Res Commun; 2017 Apr; 485(4):736-741. PubMed ID: 28257846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3.
    Yu FY; Xie CQ; Sun JT; Peng W; Huang XW
    Life Sci; 2018 Jun; 202():11-20. PubMed ID: 29577879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mmu-miR-185 regulates osteoclasts differentiation and migration by targeting Btk.
    He D; Jiao Y; Xu J; Luo J; Cui Y; Han X; Zhao H
    J Gene Med; 2024 May; 26(5):e3687. PubMed ID: 38690623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-124 regulates osteoclast differentiation.
    Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
    Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.
    Xue M; Cheng Y; Han F; Chang Y; Yang Y; Li X; Chen L; Lu Y; Sun B; Chen L
    Int J Biol Sci; 2018; 14(11):1545-1557. PubMed ID: 30263007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro.
    Baek JM; Ahn SJ; Cheon YH; Lee MS; Oh J; Kim JY
    Mol Med Rep; 2017 Feb; 15(2):784-792. PubMed ID: 28035412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
    Li M; Luo R; Yang W; Zhou Z; Li C
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-17-5p promotes the endothelialization of endothelial progenitor cells to facilitate the vascular repair of aneurysm by regulating PTEN-mediated PI3K/AKT/VEGFA pathway.
    Tian Y; Li X; Bai C; Yang Z; Zhang L; Luo J
    Cell Cycle; 2020 Dec; 19(24):3608-3621. PubMed ID: 33315517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-506 upregulation contributes to sirtuin 1 inhibition of osteoclastogenesis in bone marrow stromal cells induced by TNF-α treatment.
    Yan S; Miao L; Lu Y; Wang L
    Cell Biochem Funct; 2019 Dec; 37(8):598-607. PubMed ID: 31515847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
    Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
    J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.